Terapie digitali rimborsate per obesità e malattie croniche, integrate nei sistemi sanitari di Germania, UK e Svizzera.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Series D Plus Oviva raised a 200 million euro Series D (new equity and secondary) from Kinnevik, Planet First Partners, A.P. Moller Holding and others to bring digital obesity care to more European health systems. | $232M |
| Sep 2021 | Series C Potsdam/Swiss e-health company Oviva (digital type-2 diabetes therapy) raised USD80M from Sofina, Temasek and existing investors. | $80M |